676 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04

Regular and Young Investigator Award Abstracts(2022)

引用 0|浏览0
暂无评分
关键词
evorpacept,squamous cell carcinoma,pembrolizumab,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要